MiMedx to Present Clinical and Scientific Studies at SAWC Fall Meeting

MARIETTA, Ga.Oct. 31, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts highlighting studies on the Company’s EpiFix® dehydrated Human Amnion/Chorion Membrane (dHACM) allograft and EpiCord® dehydrated human umbilical cord (dHUC) allograft will be presented at the 2018 Symposium on Advanced Wound Care Fall (SAWC Fall) at Caesars Palace in Las Vegas, Nevada. The SAWC, now in its 31st year, is the official meeting for members of The Association for the Advancement of Wound Care and the leading national wound healing conference.


The conference begins Friday, November 2nd and concludes on Sunday, November 4th. MiMedx will be exhibiting in booth #207 during all booth times throughout the three-day meeting.


MiMedx will also sponsor a Breakfast Symposium entitled, PURION® Processed Placental Based Allografts – The Use of Bioactive Tissue Matrices in the Treatment of Wounds,” on Friday, November 2nd, from 7:30 a.m. to 9:00 a.m. The presenters during the breakfast symposium will include:


  • Michelle Massee, Manager of Biomedical Research, MiMedx
  • William Tettelbach, MD, Associate Chief Medical Officer, MiMedx
  • James Stavosky, DPM

read more